BALA CYNWYD, Pa., Sept. 29, 2022 (GLOBE NEWSWIRE) — The law firm of Brodsky & Smith announces that it is investigating potential claims against the board of directors of Signify Health, Inc. (“Signify Health” or the “Company”) ( NYSE – SGFY) for possible breaches of fiduciary duty and other violations of federal and state laws in connection with the Company’s agreement to be acquired by CVS Health® (NYSE – CVS).Under the terms of the merger agreement, Signify Health shareholders will receive 30, $50 in cash for every share of the company they own, for a total transaction value of approximately $8 billion.
The investigation concerns whether Signify Health’s board of directors failed in its fiduciary duty to shareholders by failing to conduct a fair trial and whether CVS Health® underpays the company.
If you own stock of Signify Health and would like to discuss the legal ramifications of the investigation or have any questions, you may email or call the law firm of Brodsky & Smith, who will, at no obligation or cost to you, resolve and answer your questions. You can visit Jason L. Brodsky, Esquire, or Marc L. Ackerman, Esquire at Brodsky & Smith, Two Bala Plaza, Suite 805, Bala Cynwyd, PA 19004 https://www.brodskysmith.com/cases/signify-health-inc-nyse-sgfy/or call toll-free 855-576-4847.
Brodsky & Smith is a litigation law firm with extensive experience representing shareholders nationwide in securities and class actions. Brodsky & Smith attorneys have been appointed by numerous courts across the country as lead counsel in class action lawsuits and have successfully recovered millions of dollars for our clients and shareholders. attorney advertising. Previous results do not guarantee a similar result.
